Close Icon We use cookies to improve your website experience. To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy. By continuing to use the website, you consent to our use of cookies.

Pharma Intelligence is part of the Business Intelligence Division of Informa PLC

This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Products:

Pharma Consulting

Close Icon

Hot topics

Thought leadership

Research and development strategy

Close Icon

Events

Conferences 2018

Awards

Upcoming Webinars

Webinar recordings

Close Icon

Global Search Configuration

Search Site Products & Services
Close Icon

Search by Keyword

Focus
Needs

pharmaceutical companies pharma intelligence

The partner of choice for pharmaceutical companies

Bring game-changing drugs to market more efficiently. We’ll help you understand the competition to hone in on your strategies to improve healthcare and patient outcomes.

Get drugs to market faster

adevelopment partner pharma intelligence

The right drugs developed at the right time transform pharmaceutical and biotechnology companies and improve patients’ lives. But the process is long and complex, taking place in an ever-changing, intensely competitive arena.

How we help
As the trusted pharma research partner of the top 50 global pharmaceutical companies, we provide reliable, timely intelligence and insights to help you every step of the way during drug development.

We can help you:

Optimize your clinical trials
Stay ahead of the competition by fully understanding future patient needs
Tailor your portfolio and commercial strategies to market needs
Identify opportunities and overcome potential threats across your pipeline
Stay current and be prepared for market shifts
Access historical success rates, and development and regulatory durations from a large number of perspectives

Our unique strengths

Identify market opportunities

Understand where future drug and development opportunities lie with access to the industry’s leading forecasts and behind-the-headlines analysis.

Capitalize on treatment trends

Keep on top of global trends and access source information on the impact of developing technologies.

Approach reimbursement proactively

Our reimbursement analysis can assist your business planning – both at the early stages of product development and long after product launch.

View competitor activity

Get unique competitor insight with our detailed reviews of your competitors’ clinical trials and our ability to track all drugs in development.

View more
View Less

Relevant products

Thought leadership

Key benefits:

Build brand credibility
Generate Leads
Effective reporting

Awareness

Key benefits:

Direct access to your target Pharma audience
Multi or single channel campaigns
Effective reporting

Lead generation

Key benefits:

Direct access to your target Pharma audience
Multi or single channel campaigns
Measurable results

View all content

Scrip

No, It's Not Just Out-Of-Pocket Costs That Are A Problem, John Arnold Tells Pharma

By Jessica Merrill 05 Dec 2018

The billionaire philanthropist and industry agitator took the stage at the Forbes Healthcare Summit to discuss why his foundation is focused on fixing drug pricing and supporting organizations like ICER and Patients for Affordable Drugs.

Topic Drug approval Drug development landscape Drug review

View article
Scrip

Imbruvica Replaces Chemo, Darzalex Boosts Standard Of Care In Front-Line CLL, Myeloma

By Mandy Jackson 05 Dec 2018

Late-breaker presentations at ASH showed that replacing chemotherapy agents with Imbruvica in CLL, and adding Darzalex to Revlimid and dexamethasone in multiple myeloma, is more effective than current standards of care in certain front-line settings.

Topic Cancer Drug approval

View article
Scrip

AI-Driven Drug Development Seen Blossoming In Korea As Govt Lends Support

By Jung Won Shin 05 Dec 2018

Application of artificial intelligence to new drug development in South Korea, which has been lagging in this area, is poised to accelerate as the country moves to support and encourage the technology.

Topic Drug development landscape Drug review

View article
Biomedtracker, Datamonitor Healthcare

December 2018 National Influenza Week

29 Nov 2018

3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

Topic Influenza virus Infectious diseases

Single report
Biomedtracker

Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

By Dominique Fontanilla 19 Nov 2018

Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

Topic Drug development landscape

Full video
Scrip

How Originator Companies Face Up to the Biosimilar Challenge Webinar Recording

By Eleanor Malone 16 Nov 2018

Navigating the issues presented by biosimilars is becoming more complicated. With new barriers facing biosimilar originator companies and threatening to derail development, knowing how to formulate and manage your own biosimilar action plan is critically important.

Topic Biosimilars

Full video
Trialtrove

2017 Clinical Trials Roundup The Evolution Continues

By Doro Shin 08 Nov 2018

For a detailed look at the statistics and trends surrounding clinical trials initiated in 2017, we invite you to download 2017 Clinical Trials Roundup: The Evolution Continues. Using a wealth of trial data from Trialtrove, this information-packed white paper provides a detailed analysis of Phase I–III clinical trials that were initiated last year.

Topic Clinical trials

View white paper
Scrip

Mens Health Drug Developments in Prostate Cancer

06 Nov 2018

November is Men’s Health Awareness Month, and Informa Pharma Intelligence is providing essential insights into drug developments for prostate cancer. Download now for free the "Men's Health: Drug Developments in Prostate Cancer Article Pack", brought to you by Scrip and Pink Sheet.

Topic Drug development landscape

View article
Scrip

Pfizer Well Placed To Lead First Line Advanced RCC Market

By Kevin Grogan 31 Oct 2018

Two successful Phase III studies of Inlyta in combination with two distinct immunotherapies, including its own, Merck KGaA-partnered Bavencio, puts Pfizer in a very strong position in the advanced kidney cancer market.

Topic Cancer

View article
Scrip

On Drug Price Increases, Pfizer's Read Expects ‘Business As Normal’ In 2019

By Jessica Merrill 31 Oct 2018

Presiding over his last earnings call as the CEO of Pfizer, Ian Read was pressed about the company's drug pricing strategy for 2019 amid push back from the Trump Administration.

Topic Business strategies

View article
Scrip

Scrip Awards By Numbers 2018 Video

29 Oct 2018

Just how important is it to attend SCRIP Awards 2018? We’ve put together this short video to give you the facts and figures from last year’s awards – can you afford to miss this once-a-year opportunity?

Topic Clinical trials

Full video
Scrip

A timeline of the Takeda/Shire merger

By Mike Ward 26 Oct 2018

A staple of consumer magazines and tabloid newspapers involves coverage of celebrity relationships – who has been seen together? Who is dating? Will they become a permanent item? And are they going to live happily ever after? Readers can’t seem to get enough of it. Interestingly, while maybe not so racy as the celebrity goings-on, pharma industry watchers are keen to follow company couplings. Talk of mergers and acquisitions, one of the ways that companies can build scale, always attracts attention.

Topic Business strategies Company analysis

View interactive data
Scrip

Induced Pluripotent Stem Cells Help Eisai's Hunt For Novel Parkinson's Leads

By Ian Haydock 26 Oct 2018

As part of broader efforts to pursue novel approaches to common neurological disorders, Eisai uses iPSC-derived cells to help identify potential new drug therapies for Parkinson's.

Topic Parkinsons disease

View article
Scrip

Stellar Survival Data For AZ's Lynparza Hailed At ESMO

26 Oct 2018

Clinicians and analysts have lauded spectacular results presented at ESMO from the SOLO-1 trial which strongly suggest that AstraZeneca's Lynparza should be the first-line maintenance treatment of choice for ovarian cancer patients with a BRCA mutation.

Topic Drug approval Cancer

View article
Biomedtracker

Biomedtracker Q4 2018 Outlook Report

19 Oct 2018

Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

Topic Drug development landscape

Single report

Latest headlines

Scrip

18 Dec 2018

First Approval For AZ's Roxadustat With China Green Light

Link
Scrip

18 Dec 2018

VIDEO: Synairgen Developing COPD Treatment To Hold Off Further Viral Damage

Link
Scrip

18 Dec 2018

Executives On The Move: New Hires At EUSA Pharma And Asceneuron, Promotions At Merck And Casma Therapeutics

Link
Scrip

18 Dec 2018

New Company, Big Goal: Serial Entrepreneur Jonathan Lim Launches Erasca To 'Erase Cancer'

Link
Scrip

18 Dec 2018

Evofem Plans 2019 Refiling For Amphora Based On New 86% Contraception Efficacy

Link
Scrip

17 Dec 2018

BioArctic Outlicenses Alpha-Synuclein Portfolio To AbbVie For Parkinson's

Link
Scrip

17 Dec 2018

Novo Carves Deeper Niche Into CV Market With Staten Dyslipidemia Investment

Link
Scrip

17 Dec 2018

FDA Looks To Strengthen, Speed Drug Reviews With Flow Of Quality Data

Link
Scrip

17 Dec 2018

Interview: Summit Hits The Heights With Billionaire Backing

Link
Scrip

17 Dec 2018

India E-Pharmacies Stop-Start Scenario: Will It Scare Investors?

Link
Scrip

17 Dec 2018

Mehta Analysis: Outlook For 2029

Link
Scrip

17 Dec 2018

Sophiris Will Start Phase III For Topsalysin In Prostate Cancer Despite Mixed Data Package

Link
Scrip

17 Dec 2018

Finance Watch: Alternative Funding Sources Crucial Even Amidst A Biopharma VC Boom

Link
Scrip

14 Dec 2018

Pipeline Watch: Phase III Trials Announced For AD04, Pegzilarginase And Trigriluzole

Link
Scrip

14 Dec 2018

AZ Goes Into The MYSTIC And Finds Positives For Imfinzi

Link

Next steps

Request a live demo

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Request a free demo

How can we help you?

Our team is always happy to hear from you. Please call us at:

US Toll-Free : +1 888 670 8900
US Toll : +1 908 547 2200
UK & Europe : +44 (20) 337 73737
Australia : +61 2 8705 6907
Japan : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

The partner of choice for pharmaceutical companies

Get drugs to market faster

Our unique strengths

Identify market opportunities

Capitalize on treatment trends

Approach reimbursement proactively

View competitor activity

Relevant products

Below are the Product List

Thought leadership

Awareness

Lead generation

Pharma Intelligence latest insights

Latest headlines

Next steps

This is Contactus Section

Request a live demo

How can we help you?

Pharma Report Store